Geoffrey W Melville, Jason C Siegler, Paul W M Marshall
Journal: PloS one 2017;12(8):e0182630
PMID: 28841667
D-aspartic acid (DAA) is an amino acid that is currently purported as a testosterone-boosting supplement. Research has shown that DAA supplementation increases testosterone levels in untrained men, however in trained men has been shown to produce no effect. The aim of this study was to evaluate the effects of DAA to alter testosterone levels over three months of resistance training in 22 men. Participants were randomised to receive DAA or placebo and performed 12 weeks of supervised resistance training. Blood analyses and muscle measurements were assessed at baseline, six weeks and 12 weeks. This study found that DAA supplementation is ineffective in trained men at changing testosterone levels or positively affecting training outcomes. According to these findings, the authors suggest future studies further exploring the effects of supplementation in a trained population.
CONTEXT
Research on d-aspartic acid (DAA) has demonstrated increases in total testosterone levels in untrained men, however research in resistance-trained men demonstrated no changes, and reductions in testosterone levels. The long-term consequences of DAA in a resistance trained population are currently unknown.
OBJECTIVE
To evaluate the effectiveness of DAA to alter basal testosterone levels over 3 months of resistance training in resistance-trained men.
DESIGN
Randomised, double-blind, placebo controlled trial in healthy resistance-trained men, aged 18-36, had been performing regular resistance training exercise for at least 3 d.w-1 for the previous 2 years. Randomised participants were 22 men (d-aspartic acid n = 11; placebo n = 11) (age, 23.8±4.9 y, training age, 3.2±1.5 y).
INTERVENTION
D-aspartic acid (6 g.d-1, DAA) versus equal-weight, visually-matched placebo (PLA). All participants performed 12 weeks of supervised, periodised resistance training (4 d.w-1), with a program focusing on all muscle groups.
MEASURES
Basal hormones, total testosterone (TT), free testosterone (FT), estradiol (E2), sex-hormone-binding globulin (SHBG) and albumin (ALB); isometric strength; calf muscle cross-sectional area (CSA); calf muscle thickness; quadriceps muscle CSA; quadriceps muscle thickness; evoked V-wave and H-reflexes, were assessed at weeks zero (T1), after six weeks (T2) and after 12 weeks (T3).
RESULTS
No change in basal TT or FT were observed after the intervention. DAA supplementation (n = 10) led to a 16%, 95% CI [-27%, -5%] reduction in E2 from T1-T3 (p<0.01). The placebo group (n = 9) demonstrated improvements in spinal responsiveness (gastrocnemius) at the level of the alpha motoneuron. Both groups exhibited increases in isometric strength of the plantar flexors by 17%, 95% CI [7%, 28%] (p<0.05) as well as similar increases in hypertrophy in the quadriceps and calf muscles.
CONCLUSIONS
The results of this paper indicate that DAA supplementation is ineffective at changing testosterone levels, or positively affecting training outcomes. Reductions in estradiol and the blunting of peripheral excitability appear unrelated to improvements from resistance training.
TRIAL REGISTRATION
Australian New Zealand Clinical Trials Registry ACTRN12617000041358.
Full Text Sources:
Medical:
Other Literature Sources:
Miscellaneous:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.